Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/36821800 below:

Cancer Screening in the United States During the Second Year of the COVID-19 Pandemic

Affiliations

• ¹ Surveillance & Health Equity Science Research Program, American Cancer Society, Atlanta, GA.
• ² Early Cancer Detection Science Research Program, American Cancer Society, Atlanta, GA.

• PMID: 36821800
• PMCID: PMC10911528
• DOI: 10.1200/JCO.22.02170

Item in Clipboard

Jessica Star et al. J Clin Oncol. 2023.

• ¹ Surveillance & Health Equity Science Research Program, American Cancer Society, Atlanta, GA.
• ² Early Cancer Detection Science Research Program, American Cancer Society, Atlanta, GA.

• PMID: 36821800
• PMCID: PMC10911528
• DOI: 10.1200/JCO.22.02170

Item in Clipboard

Purpose: To examine whether cancer screening prevalence in the United States during 2021 has returned to prepandemic levels using nationally representative data.

Methods: Information on receipt of age-eligible screening for breast (women age 50-74 years), cervical (women without a hysterectomy age 21-65 years), prostate (men age 55-69 years), and colorectal cancer (men and women age 50-75 years) according to the US Preventive Services Task Force recommendations was obtained from the 2019 and 2021 National Health Interview Survey. Past-year screening prevalence in 2019 and 2021 and adjusted prevalence ratios (aPRs), 2021 versus 2019, with their 95% CIs were calculated using complex survey logistic regression models.

Results: Between 2019 and 2021, past-year screening in the United States decreased from 59.9% to 57.1% (aPR, 0.94; 95% CI, 0.91 to 0.97) for breast cancer, from 45.3% to 39.0% (aPR, 0.85; 95% CI, 0.82 to 0.89) for cervical cancer, and from 39.5% to 36.3% (aPR, 0.9; 95% CI, 0.84 to 0.97) for prostate cancer. Declines were most notable for non-Hispanic Asian persons. Colorectal cancer screening prevalence remained unchanged because an increase in past-year stool testing (from 7.0% to 10.3%; aPR, 1.44; 95% CI, 1.31 to 1.58) offset a decline in colonoscopy (from 15.5% to 13.8%; aPR, 0.88; 95% CI, 0.83 to 0.95). The increase in stool testing was most pronounced in non-Hispanic Black and Hispanic populations and in persons with low socioeconomic status.

Conclusion: Past-year screening prevalence for breast, cervical, and prostate cancer among age-eligible adults in the United States continued to be lower than prepandemic levels in the second year of the COVID-19 pandemic, reinforcing the importance of return to screening health system outreach and media campaigns. The large increase in stool testing emphasizes the role of home-based screening during health care system disruptions.

[Media: see text].

PubMed Disclaimer

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center .

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians ( Open Payments ).

Priti Bandi

Employment: Syneos Health (I)

Xuesong Han

Research Funding: AstraZeneca

No other potential conflicts of interest were reported.

Number of age-eligible adults who…

Number of age-eligible adults who reported receipt of screening in the past year…

Number of age-eligible adults who reported receipt of screening in the past year in 2019 and 2021 in the United States.

• On Cancer Screening During the COVID-19 Pandemic.

  Brawley OW. Brawley OW. J Clin Oncol. 2023 Sep 20;41(27):4338-4340. doi: 10.1200/JCO.23.00284. Epub 2023 Aug 9. J Clin Oncol. 2023. PMID: 37556773 Free PMC article. No abstract available.

• Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.

  Alba C, Zheng Z, Wadhera RK. Alba C, et al. JAMA Health Forum. 2024 Feb 2;5(2):e235058. doi: 10.1001/jamahealthforum.2023.5058. JAMA Health Forum. 2024. PMID: 38306093 Free PMC article.

• Changes in Cancer Screening in the US During the COVID-19 Pandemic.

  Fedewa SA, Star J, Bandi P, Minihan A, Han X, Yabroff KR, Jemal A. Fedewa SA, et al. JAMA Netw Open. 2022 Jun 1;5(6):e2215490. doi: 10.1001/jamanetworkopen.2022.15490. JAMA Netw Open. 2022. PMID: 35657622 Free PMC article.

• Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic.

  Qian Z, Chen X, Cole AP, Abdollah F, Choueiri TK, Kibel AS, Lipsitz SR, Iyer HS, Trinh QD. Qian Z, et al. Eur Urol Oncol. 2024 Feb;7(1):151-154. doi: 10.1016/j.euo.2023.07.007. Epub 2023 Jul 22. Eur Urol Oncol. 2024. PMID: 37487814

• Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.

  Chen RC, Haynes K, Du S, Barron J, Katz AJ. Chen RC, et al. JAMA Oncol. 2021 Jun 1;7(6):878-884. doi: 10.1001/jamaoncol.2021.0884. JAMA Oncol. 2021. PMID: 33914015 Free PMC article.

• Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.

  Fedewa SA, Gansler T, Smith R, Sauer AG, Wender R, Brawley OW, Jemal A. Fedewa SA, et al. Ann Fam Med. 2018 Mar;16(2):139-144. doi: 10.1370/afm.2200. Ann Fam Med. 2018. PMID: 29531105 Free PMC article.

• Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.

  Alba C, Zheng Z, Wadhera RK. Alba C, et al. JAMA Health Forum. 2024 Feb 2;5(2):e235058. doi: 10.1001/jamahealthforum.2023.5058. JAMA Health Forum. 2024. PMID: 38306093 Free PMC article.

• Association Between COVID-19 and Planned and Postponed Cancer Screenings Among American Indian Adults Residing in California and Oklahoma, March-December 2020.

  Dang JHT, Chen S, Hall S, Campbell JE, Chen MS Jr, Doescher MP. Dang JHT, et al. Public Health Rep. 2025 Jan-Feb;140(1):57-66. doi: 10.1177/00333549241254226. Epub 2024 Jun 4. Public Health Rep. 2025. PMID: 38832678 Free PMC article.

• Predictors of Colorectal Cancer Screening and Screening Modalities among Patients seen at Federally Qualified Health Centers Funded by the United States Health Resources and Services Administration.

  Aaronson MRM, Pourat N, Lu C, Badiee J, Yu-Lefler H, Picillo B, Hoang H, May FP. Aaronson MRM, et al. Prev Med Rep. 2025 Jan 16;50:102976. doi: 10.1016/j.pmedr.2025.102976. eCollection 2025 Feb. Prev Med Rep. 2025. PMID: 39927130 Free PMC article.

• Impact of the COVID-19 Pandemic on Health Check-ups in 2021 and 2022: A Nationwide Follow-up Survey of Healthcare Facilities in Japan Society of Ningen Dock.

  Yamaguchi S, Atarashi T, Okada A, Nasu S, Yamauchi T, Arase Y, Aizawa T, Nangaku M, Kadowaki T. Yamaguchi S, et al. JMA J. 2024 Jan 15;7(1):94-105. doi: 10.31662/jmaj.2023-0126. Epub 2023 Dec 27. JMA J. 2024. PMID: 38314414 Free PMC article.

• Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.

  Sabatino SA, Thompson TD, White MC, Villarroel MA, Shapiro JA, Croswell JM, Richardson LC. Sabatino SA, et al. Prev Chronic Dis. 2023 Oct 26;20:E94. doi: 10.5888/pcd20.230071. Prev Chronic Dis. 2023. PMID: 37884318 Free PMC article.

1. 1. Centers for Disease Control and Prevention : Framework for healthcare systems providing non-COVID-19 clinical care during the COVID-19 pandemic. https://www.agd.org/docs/default-source/advocacy-papers/non-covid-19-car...
2. 1. Teglia F, Angelini M, Astolfi L, et al. : Global association of COVID-19 pandemic measures with cancer screening: A systematic review and meta-analysis. JAMA Oncol 8:1287-1293, 2022 - PMC - PubMed
3. 1. McBain RK, Cantor JH, Jena AB, et al. : Decline and rebound in routine cancer screening rates during the COVID-19 pandemic. J Gen Intern Med 36:1829-1831, 2021 - PMC - PubMed
4. 1. Song H, Bergman A, Chen AT, et al. : Disruptions in preventive care: Mammograms during the COVID-19 pandemic. Health Serv Res 56:95-101, 2021 - PMC - PubMed
5. 1. Miller MM, Meneveau MO, Rochman CM, et al. : Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors. Breast Cancer Res Treat 189:237-246, 2021 - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3